TG-2349獲准進行FDA一期臨床試驗
2011/12/08
全文»

太景生物科技獲得奈諾沙星全球獨家權利
2011/12/08
全文»

太景生技與Warner Chilcott簽署奈諾沙星授權協議
2010/10/14
全文»

TaiGen Announces Nemonoxacin (TG-873870) Once-A-Day Oral Dosing in Diabetic Foot Infection Met Primary Endpoints
2010/03/12
全文»

TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting
2009/12/07
全文»

Excellent Stem Cell Mobilization and Safety Profile for TG-0054
2009/09/28
全文»